With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, scientists and government health ...
HHS is investing more than $800 million in vaccine development and manufacturing capacity to strengthen the nation's response capabilities to emerging infectious disease threats, including bird flu.
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...
CDC officials say medical professionals are seeing more patients whose illness cannot be traced back to an infected animal or ...